1. Lee JH. Anesthesia for ambulatory surgery. Korean J Anesthesiol 2017; 70: 398-406.
2.
Awad IT, Chung F. Factors affecting recovery and discharge following ambulatory surgery. Can J Anaesth J Can Anesth 2006; 53: 858-872.
3.
Pellizzon ACA. Pain relief procedures before high-dose-rate brachytherapy for non-surgical treatment of cervix cancer. J Contemp Brachytherapy 2018; 10: 567-569.
4.
Nielsen AA, Liyanage TA, Leiserowitz GS et al. Optimal perioperative anesthesia management for gynecologic interstitial brachytherapy. J Contemp Brachytherapy 2017; 9: 216-223.
5.
Tan PW, Koh VY, Tang JI. Outpatient combined intracavitary and interstitial cervical brachytherapy: barriers and solutions to implementation of a successful programme – a single institutional experience. J Contemp Brachytherapy 2015; 7: 259-263.
6.
Gupta A, Stierer T, Zuckerman R et al. Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review. Anesth Analg 2004; 98: 632-641.
7.
Sakai EM, Connolly LA, Klauck JA. Inhalation anesthesiology and volatile liquid anesthetics: focus on isoflurane, desflurane, and sevoflurane. Pharmacotherapy 2005; 25: 1773-1788.
8.
Delgado-Herrera L, Ostroff RD, Rogers SA. Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review. CNS Drug Rev 2001; 7: 48-120.
9.
Wagner BK, O’Hara DA. Pharmacoeconomic analysis of sevoflurane versus isoflurane anesthesia in elective ambulatory surgery. Pharmacotherapy 1997; 17: 1006-1010.
10.
Maheshwari K, Ahuja S, Mascha EJ et al. Effect of sevoflurane versus isoflurane on emergence time and postanesthesia care unit length of stay: an alternating intervention trial. Anesth Analg 2020; 130: 360-366.
11.
Golembiewski J. Economic considerations in the use of inhaled anesthetic agents. Am J Health-Syst Pharm 2010; 67 (8 Suppl 4): S9-12.
12.
Moody AE, Beutler BD, Moody CE. Predicting cost of inhalational anesthesia at low fresh gas flows: impact of a new generation carbon dioxide absorbent. Med Gas Res 2020; 10: 64-66.
13.
Weinberg L, Story D, Nam J et al. Pharmacoeconomics of volatile inhalational anaesthetic agents: an 11-year retrospective analysis. Anaesth Intensive Care 2010; 38: 849-854.
14.
Chiu CL, Chan YK, Ong GS et al. A comparison of the maintenance and recovery characteristic of sevoflurane-nitrous oxide against isoflurane-nitrous oxide anaesthesia. Singapore Med J 2000; 41: 530-533.
15.
Yasuda N, Lockhart SH, Eger EI et al. Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 1991; 72: 316-324.
16.
Yasuda N, Targ AG, Eger EI. Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg 1989; 69: 370-373.
17.
Hendrix JM, Garmon EH. American Society of Anesthesiologists Physical Status Classification System. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL) 2025 (cited 2025 Dec 9). Available from: http://www.ncbi.nlm.nih.gov/books/NBK441940/
18.
Mahantshetty U, Gudi S, Singh R et al. Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy. J Contemp Brachytherapy 2019; 11: 293-306.
19.
Biro P, Kneschke O, Theusinger OM. Reliability of the volatile agent consumption display in the Draeger PrimusTM anesthesia machine. J Clin Monit Comput 2015; 29: 601-604.
20.
Mahajan VA, Ni Chonghaile M, Bokhari SA et al. Recovery of older patients undergoing ambulatory anaesthesia with isoflurane or sevoflurane. Eur J Anaesthesiol 2007; 24: 505-510.
21.
Shin JM, Park JS, Park BS et al. The comparison of recovery characteristics following anesthesia with propofol, sevoflurane or isoflurane in adults undergoing outpatient surgery. Korean J Anesthesiol 46: 213-217.
22.
Robinson BJ, Uhrich TD, Ebert TJ. A review of recovery from sevoflurane anaesthesia: comparisons with isoflurane and propofol including meta-analysis. Acta Anaesthesiol Scand 1999; 43: 185-190.
23.
Gauthier A, Girard F, Boudreault D et al. Sevoflurane provides faster recovery and postoperative neurological assessment than isoflurane in long-duration neurosurgical cases. Anesth Analg 2002; 95: 1384-1388.
24.
Campbell C, Andreen M, Battito MF et al. A phase III, multicenter, open-label, randomized, comparative study evaluating the effect of sevoflurane versus isoflurane on the maintenance of anesthesia in adult ASA class I, II, and III inpatients. J Clin Anesth 1996; 8: 557-563.
25.
Scholz J, Bischoff P, Szafarczyk W et al. Comparison of sevoflurane and isoflurane in ambulatory surgery. Results of a multicenter study. Anaesthesist 1996; 45 Suppl 1: S63-70.
26.
Ebert TJ, Robinson BJ, Uhrich TD et al. Recovery from sevoflurane anesthesia: a comparison to isoflurane and propofol anesthesia. Anesthesiology 1998; 89: 1524-1531.
27.
Seitsonen ERJ, Yli-Hankala AM, Korttila KT. Similar recovery from bispectral index-titrated isoflurane and sevoflurane anesthesia after outpatient gynecological surgery. J Clin Anesth 2006; 18: 272-279.
28.
Ries CR, Azmudéh A, Franciosi LG et al. Cost comparison of sevoflurane with isoflurane anesthesia in arthroscopic menisectomy surgery. Can J Anaesth J Can Anesth 1999; 46: 1008-1013.
29.
Mutyala S, Smith G, Ansinelli H et al. Feasibility of outpatient hybrid brachytherapy for cervical cancer with minimal sedation: Results from a single-institutional protocol. J Contemp Brachytherapy 2023; 15: 43-47.
30.
Fionda B, Placidi E, Lancellotta V et al. COMIRI – COMplexity Index of interventional Radiotherapy (brachytherapy) Implants: assessment of procedures based on type, equipment, and team. J Contemp Brachytherapy 2024; 16: 306-309.
